Relative nutritional efficacy of arginine and ornithine salts of alpha-ketoisocaproic acid in traumatized rats

Glycine-Arginine-??-Ketoisocaproic Acid Improves Performance of Repeated Cycling Sprints

PURPOSE

The purpose of this study was to determine the effect of glycine-arginine-alpha-ketoisocaproic acid (GAKIC) supplementation on repeated bouts of anaerobic cycling performance.

METHODS

Ten men completed a randomized, double-blinded, placebo-controlled exercise protocol of two sessions separated by 7 d. Plasma lactate was analyzed in blood collected 45 min before exercise (REST) and 5 min postexercise (POST). Subjects consumed either 11.2-g GAKIC or placebo (PLC) during a 45-min period between the REST and exercise. Mean power, peak power, and fatigue values were assessed from five supramaximal, 10-s cycle ergometer sprints, separated by 1-min rest intervals. Data were analyzed using repeated measures ANCOVA.

RESULTS

A significant treatment x time interaction (P = 0.039) was observed for the change in mean power output over the five sprints between the GAKIC and PLC treatments. Post hoc analyses revealed a greater retention of mean power (P = 0.038) between sprints 1 and 2 after GAKIC (-1 +/- 9 W) versus PLC treatment (-47 +/- 18 W). No other performance variables differed between PLC and GAKIC. POST lactate was increased (P < 0.001) above REST, but there was no difference between treatments (P = 0.936).

CONCLUSION

These data support an ergogenic effect of GAKIC for attenuating the decline in mean power during repeated bouts of supramaximal exercise.

High-intensity dynamic human muscle performance enhanced by a metabolic intervention

PURPOSE

The purpose of this study was to quantify the effects of a metabolic treatment on human muscle dynamic performance (strength, work, and fatigue) measured under conditions of acute, exhaustive high-intensity anaerobic isokinetic exercise.

METHODS

Unilateral prefatigue and postfatigue peak torque and work values were measured in the quadriceps femoris of 13 subjects using a computer-controlled isokinetic dynamometer, over a 23-d interval. The two experimental treatments were: 1) a glycine and L-arginine salt of alpha-ketoisocaproic acid calcium ("GAKIC"); and 2) isocaloric sucrose (control). Based on a randomized double-blind cross-over repeated measures design, measurements were made before and during an exhaustive anaerobic fatigue protocol to calculate a Fatigue Resistance Index (FRI = [peri-exhaustion torque]\[baseline peak torque]), as well as total work.

RESULTS

The FRI and total work for each of the exhaustion sets measured at 0, 5, and 15 min after oral GAKIC treatment were greater than values obtained for isocaloric control treatment (P < 0.02). GAKIC treatment increased the mean resistance to fatigue (FRI) up to 28% over isocaloric control. Overall gain in total muscle work attributable to GAKIC was 10.5 +/- 0.8% greater than control, sustained for at least 15 min. After 24 h, both GAKIC and control concentric forces returned to the same absolute values (P > 0.05): mean FRI = 0.42 +/- 0.05 and mean total work = 4600 +/- 280 J. There were no significant differences attributable to random order of testing.

CONCLUSIONS

Compared with isocaloric carbohydrate, oral GAKIC treatment increased muscle torque and work sustained during intense acute anaerobic dynamic exercise; additionally, it increased overall muscle performance by delaying muscle fatigue during the early phases of anaerobic dynamic exercise.

Addition of tyrosyl-arginine to parenteral nutrition is anabolic in unstressed rats

To determine whether the addition of tyrosine and arginine (Arg), as tyrosyl-arginine (TyrArg), to parenteral nutrition (PN) can promote anabolism, rats were assigned to: 1) PN (1.20 MJ. kg body weight [BW](-1) x d(-1) and 1.22 gN x kgBW(-1) x d(-1); PN control group, n = 5), 2) PN plus TyrArg (2.6 mmol. kgBW(-1) x d(-1); TyrArg group, n = 6), or 3) PN plus Arg (2.6 mmol. kgBW(-1). d(-1); Arg group, n = 5). Results from these three groups were compared with an unoperated chow-fed reference group (chow control group, n = 5). The BW gain during PN and the proportion of lipid in the total body after 14 d of PN was greater for the TyrArg group than for the PN group (P<0.01). Although the differences in weight gain, body water, lipid, and protein between the TyrArg and Arg groups were not significant, the mean weight gain throughout PN was greater in the TyrArg group than in the Arg group. The proportion of protein in the small intestine, colon, and gastrocnemius muscle was greater in the TyrArg and Arg groups than in the PN group (P<0.01). A distinct requirement for tyrosine has not been demonstrated in this model, and additional studies in stressed animals are required. In contrast, arginine had tissue-specific anabolic activity.

The use of alpha-ketoglutarate salts in clinical nutrition and metabolic care

Theoretically, alpha-ketoglutarate is a precursor of glutamine, a fact that may be of importance given the key regulatory properties of this amino acid. Although the literature suggests that glutamine synthesis accounts only for a marginal part of the disposal of exogenously supplied alpha-ketoglutarate, administered alpha-ketoglutarate has a potent 'sparing' effect on endogenous glutamine pools. When alpha-ketoglutarate is supplied as an ornithine salt, a synergistic effect of the two parts of the molecule increases the synthesis of glutamine or the 'sparing' of endogenous glutamine pools. In addition, alpha-ketoglutarate in combination with ornithine dramatically increases the synthesis of arginine, proline and polyamines, which also play key roles in metabolic adaptation to trauma. The recent literature suggests that the administration of alpha-ketoglutarate in combination with ornithine improves gut morphology and functions, counteracts trauma-induced dysimmunity and exerts anabolic/anticatabolic actions on protein metabolism.

Efeitos da dieta proteica na cicatrização de fraturas distais de fêmur imobilizadas com pinos intramedulares em cão

No presente experimento vinte cães sem raça definida, pesando em média 6kg, com idade variando entre 4 e 12 anos, vindos do Biotério Central da Universidade Federal de Santa Maria (UFSM), foram distribuidos em dois grupos com 10 animais, cada grupo dividido em dois subgrupos com 5 cães, denominados 1A, 1B, 2A e 2B. Os animais do grupo 1 receberam tratamento por 90 dias, e os do grupo 2 por 60 dias após a cirurgia. O subgrupo A correspondem a tratamento com ração crescimento contendo 27% de proteina bruta e o subgrupo B ração manutenção com 21% de proteina bruta. Todos os cães sofreram fratura distal de fêmur, experimental, reduzidas com dois pinos intramedulares, introduzidos através da superfície articular da tróclea. Os cães ficaram confinados em canis individuais até a remoção dos pontos e em canis comuns para no máximo 5 cães até o término do experimento. Foi feita avaliação clínica, radiográfica e histológica da evolução da cicatrização óssea a qual demonstrou que o tratamento com ração com maior teor de proteina proporcionou melhor regeneração e que a técnica de osteossíntese utilizada manteve estabilidade na linha de fratura.

Nutritional and metabolic effects and significance of mild orotic aciduria during dietary supplementation with arginine or its organic salts after trauma injury in rats

The effects of acute food deprivation and subsequent refeeding with isonitrogenous oral liquid diets supplemented with arginine (ARG), ARG alpha-ketoglutarate (AKG), or ARG alpha-ketoisocaproate (AKIC) were examined in a Sprague-Dawley rat trauma model (bilateral femur fracture). Both control and trauma rats were starved for 2 days and then pair-fed for 4 days with one of four liquid isonitrogenous diets: diet 1 was a basal casein-based diet, and diets 2, 3, and 4 were the basal diet in which 10% of the nitrogen was replaced by ARG, AKG, or AKIC nitrogen. Two days of starvation resulted in a 13% loss of body weight and also a 27% decrease in the excretion of orotic acid (OA) in control and trauma rats. Although the ARG content of diets 2, 3, and 4 was the same, ARG- and AKIC-supplemented rats excreted significantly (P < .05) more OA than AKG-fed rats. The low level of OA excretion in AKG-fed rats indicates greater use of ARG for metabolic purposes, including efficient urea cycle operation. The metabolic adaptation and nutritional efficacy, i.e., Increased nitrogen retention, larger weight gain, and altered amino acid (AA) metabolism, of AKIC rats seem to be better than in ARG- or AKG-fed rats.

Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression

OBJECTIVE

To determine whether trauma induces an increase in the concentration of circulating transforming growth factor-beta (TGF-beta), and whether there is a temporal correlation between plasma TGF-beta concentration and the development of posttrauma cellular immunosuppression.

MATERIALS AND METHODS

Male Sprague-Dawley rats were anesthetized, subjected to bilateral femur fractures or sham injury, and killed 1, 3, or 5 days later. Plasma TGF-beta levels, splenocyte phenotypes, mitogen-induced proliferation, interleukin-2 (IL-2) production, and IL-2 receptor (IL-2R) expression were determined at each time point.

MEASUREMENTS AND MAIN RESULTS

Splenocyte proliferation increased on day 1 postinjury without corresponding change in IL-2 or plasma TGF-beta levels. Splenocyte proliferation and IL-2 production were suppressed on day 3 postinjury, while plasma TGF-beta levels peaked. No differences were observed between trauma and control groups on day 5. Splenocyte phenotypes and IL-2R expression were similar in injured and control rats at all times.

CONCLUSIONS

Suppression of lymphocyte proliferation and IL-2 production after trauma occurs concomitantly with a rise in plasma TGF-beta. The immune response is restored with normalization of TGF-beta concentration. These observations suggest that TGF-beta may contribute to posttrauma immunosuppression.